As of November 2024, Shenzhen Salubris Pharmaceuticals has a market cap of $5.07B. This makes Shenzhen Salubris Pharmaceuticals the world's 2754th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.87B | -5.27% |
2023 | $5.14B | -0.58% |
2022 | $5.17B | 20.24% |
2021 | $4.30B | -3.57% |
2020 | $4.46B | 42.08% |
2019 | $3.14B | -4.55% |
2018 | $3.29B | -53.77% |
2017 | $7.11B | 54.55% |
2016 | $4.60B | -2.92% |
2015 | $4.74B | 35.94% |
2014 | $3.49B | 3.05% |
2013 | $3.39B | 34.73% |
2012 | $2.51B | 89.68% |
2011 | $1.32B | -46.30% |
2010 | $2.47B | 62.72% |
2009 | $1.52B | - |